Archive · 25 Jul 2025
Pharma Company Stock Surges on Strong Financial Results
Imagine a company called Tatva Chintan Pharma Chem that makes medicine-related stuff.
Their stocks went up a lot, like a rocket!
This happened because the company made more money than last year, especially in profit.
They also managed their money better.
A smart investor also bought some of the company's stock, showing he thinks the company will do well in the future.
The company's sales also went up, meaning they sold more stuff.
Everyone seems happy with how things are going!
Tatva Chintan Pharma Chem's stock surged 20% to a 52-week high on July 25.
The company's profit after tax increased by 27.7% to Rs 6.7 crore in Q1 FY26.
EBITDA rose 37.4% to Rs 17 crore, with operating margins expanding to 14.8%.
Revenue for the quarter was Rs 117 crore, a 10.8% increase year-over-year.
Investor Mukul Agrawal acquired a 1.28% stake, boosting investor confidence.
- Who
- Tatva Chintan Pharma Chem
- What
- Shares of Tatva Chintan Pharma Chem increased significantly.
- When
- July 25, after the announcement of Q1 FY26 results.
- Where
- BSE
- Why
- Due to strong financial results and investor confidence.
- Stock Increase
- 20%
- New High
- Rs 1,219.90
- Profit After Tax (Q1 FY26)
- Rs 6.7 crore
- EBITDA (Q1 FY26)
- Rs 17 crore
- Revenue (Q1)
- Rs 117 crore
- Investor Stake
- Mukul Agrawal (1.28%)